Centogene N.V. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 48.54 million compared to EUR 47.47 million a year ago. Net loss was EUR 35.53 million compared to EUR 31.84 million a year ago.

Basic loss per share from continuing operations was EUR 1.27 compared to EUR 1.45 a year ago. Diluted loss per share from continuing operations was EUR 1.27 compared to EUR 1.45 a year ago. Basic loss per share was EUR 1.27 compared to EUR 1.19 a year ago.

Diluted loss per share was EUR 1.27 compared to EUR 1.19 a year ago.